Warning: TLRY is at high risk of performing badly
Tilray Brands, Inc. (NASDAQ:TLRY) has characteristics which have been historically associated with poor future stock...
Tag: TLRY
Tilray Medical expands in Italy with Tilray Medical Italia launch
Tilray Medical, a division of Tilray Brands (TLRY), announced a strategic update to its medical cannabis operations in...
Tilray anticipates $150M global medical cannabis revenue run rate as international expansion accelerates
Earnings Call Insights: Tilray Brands, Inc. (TLRY) Q2 2026 CEO Irwin Simon reported, "We delivered a strong second quarter...
Tilray rises as it achieves record quarterly revenue on cannabis sales growth
Tilray Brands (TLRY) is up ~7% in after-hours trading Thursday after posting fiscal 2026 Q2 financial results that beat on...
Tilray in charts: Cannabis business inches up 3% Y/Y
Seeking AlphaSeeking AlphaSeeking AlphaSeeking Alpha
Tilray Non-GAAP EPS of -$0.02, revenue of $217.51M beats by $6.36M
Tilray press release (TLRY): Q2 Non-GAAP EPS of -$0.02. Revenue of $217.51M (+3.1% Y/Y) beats by $6.36M. Cannabis net...
Tilray Brands Q2 preview: Bottom line weakness to persist but reclassification offers hope
Tilray Brands (TLRY) is expected to post a loss in its second-quarter earnings scheduled for January 8, after the closing...
Taprooms, takeovers, and brand resets: What to expect from the craft beer industry in 2026
The craft beer business is still in a shakeout phase that began in 2023, with volumes declining and brewery closures...
Cannabis stocks selling off amid Trump’s rescheduling order
Cannabis companies were among notable underperformers on Thursday, as Wall Street was awaiting an executive order from...